These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 22223379)
1. A 5% glucose infusion fluid provokes significant precipitation of phenytoin sodium injection via interruption of the cosolvent effect of propylene glycol. Onuki Y; Ikegami-Kawai M; Ishitsuka K; Hayashi Y; Takayama K Chem Pharm Bull (Tokyo); 2012; 60(1):86-93. PubMed ID: 22223379 [TBL] [Abstract][Full Text] [Related]
2. Contribution of glucose to crystallization of phenytoin in injectable dosage form by dilution with infusion fluids. Onuki Y; Hasegawa N; Ikegami-Kawai M; Suematsu T; Sakurai S; Shirozu S; Tsubuki M; Obata Y; Takayama K Chem Pharm Bull (Tokyo); 2014; 62(10):989-93. PubMed ID: 25273057 [TBL] [Abstract][Full Text] [Related]
3. Phenytoin sodium solubility in three intravenous solutions. Pfeifle CE; Adler DS; Gannaway WL Am J Hosp Pharm; 1981 Mar; 38(3):358-62. PubMed ID: 7223749 [TBL] [Abstract][Full Text] [Related]
4. Prediction of phenytoin solubility in intravenous admixtures: physicochemical theory. Newton DW; Kluza RB Am J Hosp Pharm; 1980 Dec; 37(12):1647-51. PubMed ID: 7446539 [TBL] [Abstract][Full Text] [Related]
5. Prevention of precipitation of phenytoin in an infusion fluid by hydroxypropyl beta-cyclodextrin. McDonald C; Muzumdar PP J Clin Pharm Ther; 1998 Jun; 23(3):235-9. PubMed ID: 9831976 [TBL] [Abstract][Full Text] [Related]
6. Dissolution of phenytoin precipitate with sodium bicarbonate in an occluded central venous access device. Akinwande KI; Keehn DM Ann Pharmacother; 1995; 29(7-8):707-9. PubMed ID: 8520086 [TBL] [Abstract][Full Text] [Related]
7. Estimation of drug precipitation upon dilution of pH-cosolvent solubilized formulations. Narazaki R; Sanghvi R; Yalkowsky SH Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1203-6. PubMed ID: 17666845 [TBL] [Abstract][Full Text] [Related]
8. Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection. Singh R; Chen J; Miller T; Bergren M; Mallik R Pharm Dev Technol; 2018 Dec; 23(10):1024-1029. PubMed ID: 27973975 [TBL] [Abstract][Full Text] [Related]
9. Compatibility and pH variability of four injectable phenytoin sodium products. Markowsky SJ; Kohls PR; Ehresman D; Leppik I Am J Hosp Pharm; 1991 Mar; 48(3):510-4. PubMed ID: 2028998 [TBL] [Abstract][Full Text] [Related]
10. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids. Cloyd JC; Bosch DE; Sawchuk RJ Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117 [TBL] [Abstract][Full Text] [Related]
11. Buffer capacity and precipitation control of pH solubilized phenytoin formulations. Alvarez-Núñez FA; Yalkowsky SH Int J Pharm; 1999 Aug; 185(1):45-9. PubMed ID: 10425364 [TBL] [Abstract][Full Text] [Related]
12. Severe propylene glycol toxicity secondary to use of anti-epileptics. Pillai U; Hothi JC; Bhat ZY Am J Ther; 2014; 21(4):e106-9. PubMed ID: 22926232 [TBL] [Abstract][Full Text] [Related]
13. Crystallization of three phenytoin preparations in intravenous solutions. Giacona N; Bauman JL; Siepler JK Am J Hosp Pharm; 1982 Apr; 39(4):630-4. PubMed ID: 7081239 [TBL] [Abstract][Full Text] [Related]
14. Development of a liquid formulation of poorly water-soluble isosteviol sodium using the co-solvent technology. Lai W; Kang Q; Zou C; Li Q; Sun H; Tan W Pharm Dev Technol; 2017 Mar; 22(2):275-282. PubMed ID: 27557399 [TBL] [Abstract][Full Text] [Related]
15. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process. Thakur R; Gupta RB Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406 [TBL] [Abstract][Full Text] [Related]
16. Supersaturated state of diazepam injection following dilution with infusion fluid. Onuki Y; Hasegawa N; Kida C; Ikegami-Kawai M; Tsubuki M; Shirozu S; Obata Y; Takayama K J Pharm Health Care Sci; 2015; 1():9. PubMed ID: 26819720 [TBL] [Abstract][Full Text] [Related]
17. Guidelines for phenytoin infusions. Tuttle CB Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318 [TBL] [Abstract][Full Text] [Related]
18. Aqueous solvent system for the solubilization of azole compounds. Kovács K; Stampf G; Klebovich I; Antal I; Ludányi K Eur J Pharm Sci; 2009 Feb; 36(2-3):352-8. PubMed ID: 19022381 [TBL] [Abstract][Full Text] [Related]
19. Crystallization of toxic glycol solvates of rifampin from glycerin and propylene glycol contaminated with ethylene glycol or diethylene glycol. de Villiers MM; Caira MR; Li J; Strydom SJ; Bourne SA; Liebenberg W Mol Pharm; 2011 Jun; 8(3):877-88. PubMed ID: 21401126 [TBL] [Abstract][Full Text] [Related]
20. Physicochemical properties of valsartan and the effect of ethyl alcohol, propylene glycol and pH on its solubility. Mbah CJ Pharmazie; 2005 Nov; 60(11):849-50. PubMed ID: 16320948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]